Published in Medical Letter on the CDC and FDA, November 21st, 2004
This largest malaria vaccine efficacy trial ever conducted in Africa also reconfirmed the vaccine's safety in one-to-4 year old children. Further efficacy studies will be needed before consideration for licensure.
The double-blind, controlled trial involved 2,022 children in southern Mozambique...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.